In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

AbCellera Biologics Inc.

http://www.abcellera.com

Latest From AbCellera Biologics Inc.

Coronavirus Update: Lilly Initiates 2,400-Patient Nursing Home Trial

Dozens of specially outfitted RVs will roll out to long-term care facilities in the US to test the prophylactic and symptom-reducing potential of the antibody Lilly is developing with AbCellera.

Coronavirus COVID-19 Clinical Trials

Lilly May Face Q2 Blues As Prior Stocking Takes Effect

Changing payer mix in diabetes due to the impacts of COVID-19 may be a central focus of Lilly's second quarter earnings call.

Sales & Earnings Business Strategies

US DoJ Lets Biotechs Share Manufacturing Details To Speed Launch Of COVID-19 Therapies

Companies are shielded from antitrust concerns by Justice Department as they jointly prepare to manufacture whichever monoclonal-antibody-based coronavirus therapies emerge from development.

Coronavirus COVID-19 Manufacturing

Coronavirus Update: Regeneron Races Into Phase III Trial Of Antibodies To Block Coronavirus Infection

Regeneron and NIAID kick off a Phase III prevention trial for antibody cocktail REGN-COV2.

Coronavirus COVID-19 Clinical Trials
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
      • Antibodies
    • Drug Discovery Tools
      • Genomics-Proteomics
UsernamePublicRestriction

Register